Dr. Le received his Ph.D. degree in Immunology and Molecular Genetics, and a medical degree (M.D.) from the Medical Scientist Training Program at the University of California, Los Angeles (UCLA). He completed an Internship in Internal Medicine at UCLA/St. Mary Medical Center, residency training in Dermatology and a postdoctoral fellowship in Cancer Biology from University of Texas Southwestern Medical Center. He is board certified by the American Board of Dermatology. Dr. Le sees patients in the Dermatology clinic and at the UTSW Neurofibromatosis clinic.
Dr. Le’s scientific contributions began at UCLA, where he initiated his Ph.D. thesis project in the laboratory of Professor Owen Witte to investigate the molecular and cellular functions of a lymphocyte-expressed G protein coupled receptor and its role in BCR-ABL mediated leukemogenesis. His thesis work established this receptor as a regulator of lymphocyte proliferation, autoimmunity and inflammation, thus demonstrating how this moiety contributes to immunological tolerance, autoimmunity and neoplastic responses in lymphocytes [Cancer Cell 1(4): 381-391; Immunity 14(5), 561-571; Proc. Natil. Acad. Sci. USA 97, 12109 – 12114].
It was working on BCR-ABL and chronic myelogenous leukemia, that Dr. Le developed an interest in tumor microenvironment and tumor cell of origin. As a natural extension of his doctoral work, Dr. Le was obsessed to tackle two fundamental questions in cancer biology: how does permissive tumor microenvironment, such as inflammation or hapoinsufficiency, regulates tumorigenesis in a non-cell autonomous fashion. His second interest lies in the understanding of how cancers originate and develop from adult stem cells in a certain organ of the body. His postdoctoral works in the laboratory of Professor Luis Parada defined the cell of origin for Neurofibromatosis Type I (NF1)-associated cutaneous neurofibromas and generated a novel mouse model for this complex tumor. It also provided strong evidences that loss of NF1 is required but not sufficient to induce neurofibroma, pointing to the essential role for the tumor microenvironment, including neurons, mast cells and hormones, in neurofibroma development. Additionally, while focused on neurofibroma, this work raises the exciting possibility that the surrounding non-neoplastic cells in the tumor environment may also impact the growth of other tumor types. An increased understanding of the role of non-neoplastic tumor-associated cells may lead to new directions for cancer therapy and prevention [Cell Stem Cell. 4 (5): 453-463; Cancer Research. 71(13): 4686-95; Oncogene. 26(32): 4609-4616].
The contributions described above provide the groundwork for current work in his laboratory – investigations aimed at defining how early, initiating genetic and microenvironmental factors interplay to regulate tumorigenesis. His laboratory utilizes NF1, a common tumor predisposition human genetic disorder, as a model to address these fundamental questions of cancer biology. His laboratory has recapitulated human neurofibromatosis in murine models to decipher mechanisms that initiate Neurofibroma formation and drive their malignant transformation. These studies published from his laboratory addressed fundamental, unanswered questions in the neurofibromatosis field [Cancer Cell 26(5): 695-706; Cell Reports. 6(1): 81-92; Cancer Research. 74(2): 586-97; Cell. 152(5): 1077-1090; Stem Cells. 30(10): 2261-70]. While working on neurofibromatosis, his research group serendipitously uncovered the identity of follicular epithelial cells that directly give rise to hair and mechanisms that cause hair to turn gray [Genes & Development. 31(8): 744-756] – findings that could one day help identify possible treatments for balding and hair graying.
Outside the lab, Dr. Le enjoys biking with his children, reading and spending time with family and friends.